Pulmonary Tuberculosis IV
Pulmonary Tuberculosis II
Pulmonary Tuberculosis I
Pulmonary Tuberculosis III
Pulmonary Tuberculosis V
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 14, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Haiqin Jiang1, Lemuel Tsang2, Hongsheng Wang3
1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Interferon-induced protein 44-like (IFI44L) restricts Mycobacterium tuberculosis survival in macrophages. Upregulated IFI44L expression in tuberculosis patients suggests its potential as a therapeutic target for treating this infection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: